Auxano Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
2,309
+108
| +5% | +$84.2K | 0.42% | 33 |
|
|
2025
Q1 | $1.82M | Sell |
2,201
-49
| -2% | -$40.5K | 0.48% | 32 |
|
|
2024
Q4 | $1.74M | Buy |
2,250
+578
| +35% | +$446K | 0.44% | 35 |
|
|
2024
Q3 | $1.48M | Buy |
1,672
+1
| +0.1% | +$886 | 0.38% | 44 |
|
|
2024
Q2 | $1.51M | Buy |
1,671
+23
| +1% | +$20.8K | 0.42% | 42 |
|
|
2024
Q1 | $1.28M | Buy |
1,648
+191
| +13% | +$149K | 0.37% | 46 |
|
|
2023
Q4 | $849K | Sell |
1,457
-72
| -5% | -$42K | 0.29% | 58 |
|
|
2023
Q3 | $821K | Sell |
1,529
-24
| -2% | -$12.9K | 0.34% | 47 |
|
|
2023
Q2 | $533K | Hold |
1,553
| – | – | 0.21% | 61 |
|
|
2023
Q1 | $533K | Buy |
1,553
+88
| +6% | +$30.2K | 0.21% | 61 |
|
|
2022
Q4 | $536K | Buy |
1,465
+80
| +6% | +$29.3K | 0.24% | 58 |
|
|
2022
Q3 | $448K | Buy |
1,385
+28
| +2% | +$9.06K | 0.21% | 60 |
|
|
2022
Q2 | $440K | Buy |
1,357
+63
| +5% | +$20.4K | 0.22% | 49 |
|
|
2022
Q1 | $371K | Hold |
1,294
| – | – | 0.16% | 54 |
|
|
2021
Q4 | $357K | Hold |
1,294
| – | – | 0.16% | 52 |
|
|
2021
Q3 | $299K | Hold |
1,294
| – | – | 0.13% | 51 |
|
|
2021
Q2 | $297K | Buy |
1,294
+15
| +1% | +$3.44K | 0.14% | 52 |
|
|
2021
Q1 | $239K | Hold |
1,279
| – | – | 0.15% | 52 |
|
|
2020
Q4 | $216K | Buy |
+1,279
| New | +$216K | 0.14% | 48 |
|
|
2020
Q3 | – | Sell |
-1,279
| Closed | -$210K | – | 47 |
|
|
2020
Q2 | $210K | Buy |
+1,279
| New | +$210K | 0.17% | 40 |
|